Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU.
Ravaud
Alain
A
de la Fouchardière
Christelle
C
Asselineau
Julien
J
Delord
Jean-Pierre
JP
Do Cao
Christine
C
Niccoli
Patricia
P
Rodien
Patrice
P
Klein
Marc
M
Catargi
Bogdan
B
D006801:Humans; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018276:Carcinoma, Medullary / Q000188:drug therapy; D007211:Indoles / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D000077210:Sunitinib; D013964:Thyroid Neoplasms / Q000188:drug therapy; D017322:Clinical Trials, Phase II as Topic
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib